4.6 Article

Association of Osteoarthritis With Changes in Structural Neuroimaging Markers Over Time Among Non-demented Older Adults

Journal

FRONTIERS IN AGING NEUROSCIENCE
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fnagi.2021.664443

Keywords

osteoarthritis; MRI; neuroimaging; dementia; longitudinal study

Funding

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI
  2. National Institutes of Health) [U01 AG024904]
  3. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  4. National Institute on Aging
  5. National Institute of Biomedical Imaging and Bioengineering
  6. AbbVie
  7. Alzheimer's Association
  8. Alzheimer's Drug Discovery Foundation
  9. Araclon Biotech
  10. BioClinica, Inc
  11. Biogen
  12. Bristol-Myers Squibb Company
  13. CereSpir, Inc
  14. Cogstate
  15. Eisai Inc
  16. Elan Pharmaceuticals, Inc
  17. Eli Lilly and Company
  18. EuroImmun
  19. F. Hoffmann-La Roche Ltd
  20. Genentech, Inc
  21. Fujirebio
  22. GE Healthcare
  23. Janssen Alzheimer Immunotherapy Research and Development, LLC
  24. Johnson and JIXICO Ltdohnson Pharmaceutical Research and Development LLC
  25. Lumosity
  26. Lundbeck
  27. Merck and Co., Inc
  28. Meso Scale Diagnostics, LLC
  29. NeuroRx Research
  30. Neurotrack Technologies
  31. Novartis Pharmaceuticals Corporation
  32. Pfizer Inc
  33. Piramal Imaging
  34. Servier
  35. Takeda Pharmaceutical Company
  36. Transition Therapeutics
  37. The Canadian Institutes of Health Research

Ask authors/readers for more resources

This study found that while no significant differences were observed in structural neuroimaging markers between osteoarthritis (OA) and non-OA groups in the cross-sectional analysis, a steeper decline in volumes of gray matter of the whole brain was associated with OA in non-demented older adults in the longitudinal analysis.
Objective: Although emerging evidence suggests that both osteoarthritis (OA) and brain atrophy (as assessed by structural neuroimaging markers) are associated with the risk of dementia, little is known about the association between OA and structural neuroimaging markers. This study aimed to examine the association of OA with changes in structural neuroimaging markers among non-demented older people. Methods: We examined the cross-sectional and longitudinal associations between OA and structural neuroimaging markers (hippocampal volume, entorhinal volume, ventricular volume, and volume of gray matter of the whole brain) among non-demented older people. We categorized our participants as those without OA (OA-) and those with OA (OA+). At baseline, we included 1,281 non-demented older adults, including 1,050 without OA and 231 with OA. Results: In the cross-sectional analysis, we did not observe any significant difference in structural neuroimaging markers between the two OA groups. In the longitudinal analysis, we found that compared to participants without OA, those with OA showed a steeper decline in volumes of the gray matter of the whole brain among non-demented older adults. Conclusions: OA was associated with a steeper decline in volumes of the gray matter of the whole brain over time among non-demented older people.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available